BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

Terms: = Head and neck cancer AND NFIB, RP11-280O24_2, 4781, ENSG00000147862, NFIB2, NFI-RED, NFIB3 AND Treatment
38152 results:

  • 1. Surgical and multimodal treatment of metastatic oesophageal cancer: retrospective cohort study.
    Knipper K; Lemties J; Krey T; Lyu SI; Wirsik NM; Schiffmann LM; Fuchs HF; Gebauer F; Schröder W; Popp FC; Quaas A; Schlößer HA; Bruns CJ; Schmidt T
    BJS Open; 2024 May; 8(3):. PubMed ID: 38814750
    [TBL] [Abstract] [Full Text] [Related]  

  • 2. Immune checkpoint inhibitors as the second-line treatment for advanced esophageal squamous cell carcinoma: a cost-effectiveness analysis based on network meta-analysis.
    Yang X; Zheng X; Hu S; Huang J; Zhang M; Huang P; Wang J
    BMC Cancer; 2024 May; 24(1):654. PubMed ID: 38811891
    [TBL] [Abstract] [Full Text] [Related]  

  • 3. Analysis of the association between salivary proteins and oral mucositis in patients with head and neck cancer undergoing IMRT: a longitudinal study.
    Agurto MG; Carpenter GH; Bozorgi SS; Koller G; Fenlon M; Warburton F; Bruce K; Burke M; Banerjee A
    BMC Oral Health; 2024 May; 24(1):630. PubMed ID: 38811865
    [TBL] [Abstract] [Full Text] [Related]  

  • 4. The enhanced energy metabolism in the tumor margin mediated by RRAD promotes the progression of oral squamous cell carcinoma.
    Cheng A; Xu Q; Li B; Zhang L; Wang H; Liu C; Han Z; Feng Z
    Cell Death Dis; 2024 May; 15(5):376. PubMed ID: 38811531
    [TBL] [Abstract] [Full Text] [Related]  

  • 5. Assessment of the Dosimetric Index from IMRT and Rapid arc Plan for Oropharyngeal cancer with Simultaneous Integrated Boost (SIB) Technique in Combination with EUD-based NTCP and TCP Radiobiological Models.
    Dashnamoorthy S; Jeyasingh E; Rajamanickam K; Ahmed I
    Asian Pac J Cancer Prev; 2024 May; 25(5):1515-1528. PubMed ID: 38809623
    [TBL] [Abstract] [Full Text] [Related]  

  • 6. Radiotherapy for parotid cancer: 10 years of experience in a single center.
    Lachgar A; N'Da G; Nouni K; El Kacemi H; Kebdani T; Hassouni K
    Otolaryngol Pol; 2024 Jun; 78(3):1-6. PubMed ID: 38808641
    [TBL] [Abstract] [Full Text] [Related]  

  • 7. Deep Learning-Based Prediction of Radiation Therapy Dose Distributions in Nasopharyngeal Carcinomas: A Preliminary Study Incorporating Multiple Features Including Images, Structures, and Dosimetry.
    Wang Y; Piao Z; Gu H; Chen M; Zhang D; Zhu J
    Technol Cancer Res Treat; 2024; 23():15330338241256594. PubMed ID: 38808514
    [No Abstract]    [Full Text] [Related]  

  • 8. Cost-effectiveness analysis of tislelizumab vs. camrelizumab for the treatment of second-line locally advanced or metastatic esophageal squamous cell carcinoma.
    Chen P; Fu C; Shen L; Fei Z; Luo M; Chen Y; Li H
    BMC Health Serv Res; 2024 May; 24(1):676. PubMed ID: 38807104
    [TBL] [Abstract] [Full Text] [Related]  

  • 9. Practical surgical technique using the SMISS approach for lip reduction in involuted lip infantile hemangiomas.
    Chen Q; Chang SJ; Gao W; Chang L; Qiu Y; Lin X
    BMC Pediatr; 2024 May; 24(1):368. PubMed ID: 38807073
    [TBL] [Abstract] [Full Text] [Related]  

  • 10. Tislelizumab plus chemotherapy versus placebo plus chemotherapy as first line treatment for advanced gastric or gastro-oesophageal junction adenocarcinoma: RATIONALE-305 randomised, double blind, phase 3 trial.
    Qiu MZ; Oh DY; Kato K; Arkenau T; Tabernero J; Correa MC; Zimina AV; Bai Y; Shi J; Lee KW; Wang J; Poddubskaya E; Pan H; Rha SY; Zhang R; Hirano H; Spigel D; Yamaguchi K; Chao Y; Wyrwicz L; Disel U; Cid RP; Fornaro L; Evesque L; Wang H; Xu Y; Li J; Sheng T; Yang S; Li L; Moehler M; Xu RH;
    BMJ; 2024 May; 385():e078876. PubMed ID: 38806195
    [TBL] [Abstract] [Full Text] [Related]  

  • 11. [Our experience in the treatment of congenital nasal median heterotopias in children and an overview of various treatment tactics].
    Molodtsova EV; Yunusov AS; Daikhes NA; Polyakov DP; Korobkin AS; Larina OM
    Vestn Otorinolaringol; 2024; 89(2):28-32. PubMed ID: 38805460
    [TBL] [Abstract] [Full Text] [Related]  

  • 12. Influence of radiotherapy interruption on esophageal cancer with intensity-modulated radiotherapy: a retrospective study.
    Mou Y; Liang P; Cheng X; He X; Zhang J; Liu L; Liu Q
    BMC Cancer; 2024 May; 24(1):646. PubMed ID: 38802765
    [TBL] [Abstract] [Full Text] [Related]  

  • 13. Risk for cancer development in familial Mediterranean fever and associated predisposing factors: an ambidirectional cohort study from the international AIDA Network registries.
    Vitale A; Caggiano V; Tufan A; Ragab G; Batu ED; Portincasa P; Aragona E; Sota J; Conti G; De Paulis A; Rigante D; Olivieri AN; Şahin A; La Torre F; Lopalco G; Cattalini M; Maggio MC; Insalaco A; Sfikakis PP; Verrecchia E; Yildirim D; Kucuk H; Kardas RC; Laymouna AH; Ghanema M; Saad MA; Sener S; Ercan Emreol H; Ozen S; Jaber N; Khalil M; Di Ciaula A; Gaggiano C; Malizia G; Affronti A; Patroniti S; Romeo M; Sbalchiero J; Della Casa F; Mormile I; Silvaroli S; Gicchino MF; Çelik NÇ; Tarsia M; Karamanakos A; Hernández-Rodríguez J; Parronchi P; Opris-Belinski D; Barone P; Recke A; Costi S; Sfriso P; Giardini HAM; Gentileschi S; Wiesik-Szewczyk E; Vasi I; Loconte R; Jahnz-Różyk K; Martín-Nares E; Torres-Ruiz J; Cauli A; Conforti A; Emmi G; Li Gobbi F; Biasi GR; Terribili R; Ruscitti P; Del Giudice E; Tharwat S; Brucato AL; Ogunjimi B; Hinojosa-Azaola A; Balistreri A; Fabiani C; Frediani B; Cantarini L
    Front Immunol; 2024; 15():1397890. PubMed ID: 38799474
    [TBL] [Abstract] [Full Text] [Related]  

  • 14. The Relationship between miR-5682 and Nutritional Status of Radiotherapy-Treated Male Laryngeal cancer Patients.
    Mazurek M; Brzozowska A; Maziarz M; Małecka-Massalska T; Powrózek T
    Genes (Basel); 2024 Apr; 15(5):. PubMed ID: 38790185
    [TBL] [Abstract] [Full Text] [Related]  

  • 15. cancer-associated stroke from progressive acinic cell carcinoma.
    Garcia JJB; Pascual JLV
    BMJ Case Rep; 2024 May; 17(5):. PubMed ID: 38789271
    [TBL] [Abstract] [Full Text] [Related]  

  • 16. Advances in Diagnostic, Staging, and Restaging Evaluation of Esophageal and Gastric cancer.
    Nobel T; Sihag S
    Surg Oncol Clin N Am; 2024 Jul; 33(3):467-485. PubMed ID: 38789190
    [TBL] [Abstract] [Full Text] [Related]  

  • 17. Clinical inertia in thyrotropin suppressive therapy for low-risk differentiated thyroid cancer: A real-world experience at an endocrine center in Bangkok.
    Thewjitcharoen Y; Chatchomchuan W; Wanothayaroj E; Butadej S; Nakasatien S; Krittiyawong S; Rajatanavin R; Himathongkam T
    Medicine (Baltimore); 2024 May; 103(21):e38290. PubMed ID: 38788029
    [TBL] [Abstract] [Full Text] [Related]  

  • 18. Predictive role of Naples prognostic score for survival in esophageal cancer: A meta-analysis.
    Guo H; Wang T
    Medicine (Baltimore); 2024 May; 103(21):e38160. PubMed ID: 38787991
    [TBL] [Abstract] [Full Text] [Related]  

  • 19. Accelerated Fractionated Radiation Therapy for Localized Glottic Carcinoma.
    Mizukami T; Yamagishi K; Tobikawa M; Nakazato A; Abe H; Morita Y; Saitoh JI
    Curr Oncol; 2024 May; 31(5):2636-2643. PubMed ID: 38785479
    [TBL] [Abstract] [Full Text] [Related]  

  • 20. Efficacy and safety of eribulin mesylate in patients with locally advanced or metastatic breast cancer previously treated with anthracycline/taxanes.
    Chen L; Yan X; Luo T; Tian T; He P; Zhong X
    Cancer Med; 2024 May; 13(10):e7295. PubMed ID: 38785215
    [TBL] [Abstract] [Full Text] [Related]  


    [Next]

    of 1908.